BGLC

BioNexus Gene Lab Corp.

Contracts

Total Value

Stock Metrics

0.4%

Short % Float

1.0d to cover · Low squeeze

0.6%

Inst % Float

3 holders · 2026-06-30

HRT Financial LP

Top Holder

0.6% of float

1.8M sh

Public Float

32/100

Dilution Score

Medium

26 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

32/100

MEDIUM

Inst: 0.6% · Top: HRT Financial LP

Biotech Analytics

Biotech / Pharma

5.61

Biotech Grade: F

Insider Buying0

Dilution Risk32

Clinical Trials0

Short Interest10